These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 25936860)
1. Phospholipid-stabilized mesoporous carbon nanospheres as versatile carriers for systemic delivery of amphiphobic SNX-2112 (a Hsp90 inhibitor) with enhanced antitumor effect. Zhang X; Zhang T; Ye Y; Chen H; Sun H; Zhou X; Ma Z; Wu B Eur J Pharm Biopharm; 2015 Aug; 94():30-41. PubMed ID: 25936860 [TBL] [Abstract][Full Text] [Related]
2. Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport. Ye Y; Zhang T; Li W; Sun H; Lu D; Wu B; Zhang X Pharm Res; 2016 Mar; 33(3):792-803. PubMed ID: 26553355 [TBL] [Abstract][Full Text] [Related]
3. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90. Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568 [TBL] [Abstract][Full Text] [Related]
4. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression. Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420 [TBL] [Abstract][Full Text] [Related]
5. Chitosan-functionalised single-walled carbon nanotube-mediated drug delivery of SNX-2112 in cancer cells. Zheng L; Wu S; Tan L; Tan H; Yu B J Biomater Appl; 2016 Sep; 31(3):379-86. PubMed ID: 27231263 [TBL] [Abstract][Full Text] [Related]
6. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts. Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560 [TBL] [Abstract][Full Text] [Related]
7. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
8. Ligand-conjugated mesoporous silica nanorattles based on enzyme targeted prodrug delivery system for effective lung cancer therapy. Sundarraj S; Thangam R; Sujitha MV; Vimala K; Kannan S Toxicol Appl Pharmacol; 2014 Mar; 275(3):232-43. PubMed ID: 24467950 [TBL] [Abstract][Full Text] [Related]
9. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy. Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735 [TBL] [Abstract][Full Text] [Related]
10. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo. Liu KS; Ding WC; Wang SX; Liu Z; Xing GW; Wang Y; Wang YF Oncol Rep; 2012 Jun; 27(6):1904-10. PubMed ID: 22447251 [TBL] [Abstract][Full Text] [Related]
11. The Hsp90 inhibitor SNX-2112 induces apoptosis of human hepatocellular carcinoma cells: the role of ER stress. Wang X; Wang S; Liu Y; Ding W; Zheng K; Xiang Y; Liu K; Wang D; Zeng Y; Xia M; Yang D; Wang Y Biochem Biophys Res Commun; 2014 Mar; 446(1):160-6. PubMed ID: 24582562 [TBL] [Abstract][Full Text] [Related]
12. SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Chandarlapaty S; Sawai A; Ye Q; Scott A; Silinski M; Huang K; Fadden P; Partdrige J; Hall S; Steed P; Norton L; Rosen N; Solit DB Clin Cancer Res; 2008 Jan; 14(1):240-8. PubMed ID: 18172276 [TBL] [Abstract][Full Text] [Related]
13. SNX-2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells. Wang SX; Ju HQ; Liu KS; Zhang JX; Wang X; Xiang YF; Wang R; Liu JY; Liu QY; Xia M; Xing GW; Liu Z; Wang YF Biosci Biotechnol Biochem; 2011; 75(8):1540-5. PubMed ID: 21821931 [TBL] [Abstract][Full Text] [Related]
14. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS. Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941 [TBL] [Abstract][Full Text] [Related]
15. Carboxylated mesoporous carbon microparticles as new approach to improve the oral bioavailability of poorly water-soluble carvedilol. Zhang Y; Zhi Z; Li X; Gao J; Song Y Int J Pharm; 2013 Sep; 454(1):403-11. PubMed ID: 23850816 [TBL] [Abstract][Full Text] [Related]
16. Comparative effects of SNX-7081 and SNX-2112 on cell cycle, apoptosis and Hsp90 client proteins in human cancer cells. Wang X; Wang S; Liu Y; Huang D; Zheng K; Zhang Y; Wang X; Liu Q; Yang D; Wang Y Oncol Rep; 2015 Jan; 33(1):230-8. PubMed ID: 25334086 [TBL] [Abstract][Full Text] [Related]
17. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo. Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796 [TBL] [Abstract][Full Text] [Related]
18. In vivo studies of octreotide-modified N-octyl-O, N-carboxymethyl chitosan micelles loaded with doxorubicin for tumor-targeted delivery. Zou A; Chen Y; Huo M; Wang J; Zhang Y; Zhou J; Zhang Q J Pharm Sci; 2013 Jan; 102(1):126-35. PubMed ID: 23073894 [TBL] [Abstract][Full Text] [Related]
19. Ultrafast Low-Temperature Photothermal Therapy Activates Autophagy and Recovers Immunity for Efficient Antitumor Treatment. Deng X; Guan W; Qing X; Yang W; Que Y; Tan L; Liang H; Zhang Z; Wang B; Liu X; Zhao Y; Shao Z ACS Appl Mater Interfaces; 2020 Jan; 12(4):4265-4275. PubMed ID: 31903741 [TBL] [Abstract][Full Text] [Related]
20. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells. Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]